“It’s Time to Badger Congress —- Yet Again, Pretty Please!
If you read my previous post ,you will see Senator McCain’s plan to eliminate the Prostate Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP). The loss of this program could shorten many of [...]
Testaxel – A New Phase 2 Trial for Men Who Are Chemo Naive and Who Have Failed Chemotherapy
A new Phase 2 clinical trial of tesetaxel in men with castrate resistant advanced prostate cancer will be conducted through the Prostate Cancer Clinical Trials Consortium (PCCTC). Tesetaxel, an oral taxane which is in clinical [...]
The Washington Post and DOD Funding – Let Your Comments Be Seen By the Members of Congress
The Washington Post has written an article about the funding controversy surrounding the Department of Defense (DOD) Medical Research Programs. I urge everyone to go to the web site and add your comments. Members of [...]
Senator McCain Attacks Cancer Funding
I am in Orlando Florida attending the Department of Defense Impact Conference for the Prostate Cancer Research Program (PCRP) This DOD program is among the largest funders of prostate cancer research in the world and [...]
A Phase II Study Demonstrates that Docetaxel and Epirubicin Is Superior to Docetaxel and Prednisone in Advanced Prostate Cancer
Researchers at the Medical Oncology Unit, University of Siena, Viale Bracci 11, 53100, Siena, Italy performed a randomized phase II study which compared the activity and safety of the combination docetaxel (D)/epirubicin (EPI) with the [...]
Radio Interviews on Prostate Cancer
Tomorrow, Wednesday- March 2, I will be joining Dr. Daniel Petrylak for a number of radio interviews about prostate cancer. Dr. Petrylak is a world renowned prostate cancer researcher and clinician. He was the principal [...]